Osaic Holdings
OKUR

Osaic Holdings’s OnKure Therapeutics OKUR Stock Holding History

Osaic Holdings’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$410 Hold
90
– – ﹤0.01% 7687
2026
Q1 		$372 Sell
90
-19
-17% -$59 ﹤0.01% 7486
2025
Q4 		$316 Buy
109
+9
+9% +$27 ﹤0.01% 7512
2025
Q3 		$275 Hold
100
– – ﹤0.01% 7655
2025
Q2 		$239 Buy
+100
New +$262 ﹤0.01% 7476
2025
Q1 		– Sell
-152
Closed -$1.31K – 7768
2024
Q4 		$1.31K Sell
152
-1
-0.7% -$15 ﹤0.01% 6750
2024
Q3 		$2.59K Buy
+153
New +$2.26K ﹤0.01% 6503
2024
Q2 		– Sell
-4
Closed -$68 – 7655
2024
Q1 		$68 Hold
4
– – ﹤0.01% 7066
2023
Q4 		$66 Sell
4
-6
-60% -$374 ﹤0.01% 7146
2023
Q3 		$762 Buy
+10
New +$680 ﹤0.01% 6901

Other funds holding OKUR

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Osaic Holdings's OKUR Position: Q2 2026 in Review

Osaic Holdings held its OnKure Therapeutics (OKUR) position steady in Q2 2026 at 90 shares worth $410. The position accounts for ﹤0.01% of the portfolio, ranked #7687.

Osaic Holdings first reported a position in OKUR in Q3 2023 and has held it in 10 quarters since. The position peaked at $2.59K in Q3 2024. 75 funds tracked by Wall St. Rank hold OKUR as of Q2 2026.

  • Osaic Holdings held 90 shares of OnKure Therapeutics worth $410 as of Q2 2026.
  • Osaic Holdings left its OnKure Therapeutics share count unchanged in Q2 2026.
  • OnKure Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7687 holding.
  • Osaic Holdings first reported a position in OnKure Therapeutics in Q3 2023 and has held it in 10 quarters since.
  • Osaic Holdings's OnKure Therapeutics position peaked at $2.59K in Q3 2024.
  • 75 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.